pancreatic cancer

  •  
  •   George Lundberg, MD

    Research paper from The Journal of the American Medical Association (JAMA) curated by Editor in Chief George Lundberg, MD, who notes: 

    The U.S. Preventive Services Task Force recommends against screening for pancreatic cancer in asymptomatic adults.

    Go to full paper published in JAMA.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD:

    The pancreas is made up of three main cellular components: glands, ducts, and hormone-producing cells, some of which are known as neuroendocrine cells. All can develop malignant tumors, with very different characteristics.

    To learn more about pancreatic neuroendocrine tumors, which begin in neuroendocrine cells in the pancreas, check out this comprehensive, authoritative, detailed, up-to-date, unbiased overview from Medscape. (Free registration may be required to view the content.)

  •   George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD:

    The National Cancer Institute has put together this useful guide to pancreatic cancer for patients and caregivers. (Click here for a different version for health professionals.)

  •   George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD:

    The National Cancer Institute has put together this useful guide to pancreatic cancer, aimed for an audience of oncology professionals. (Click here for the patient-oriented version.)

  •  

    Navigating Pancreatic Cancer—The Basics

    With: Lola Rahib, PhD

    A Q&A with Lola Rahib, PhD, Lead Scientist, Pancreas Cancer, at Cancer Commons, Los Altos, CA; lola.rahib@cancercommons.org Q: Navigating a pancreatic cancer diagnosis can be overwhelming and confusing for patients and their loved ones. How can patients and their caregivers ensure having the knowledge, support, and plan they need to be able to navigate treatment options and other aspects of the disease? A: Patients… Read more »

  •  

    Serious Caveats in Screening for Pancreatic Cancer

    With: Rama Gullapalli, MD, PhD

    A Q&A with Rama Gullapalli, MD, PhD; a physician-scientist in the departments of Pathology, Chemical and Biological Engineering at the University of New Mexico. His research lab focuses on the role of the environment in hepatobiliary cancers. He is also a practicing molecular pathologist with an interest in emerging molecular diagnostics, next generation sequencing and bioinformatics. Email: rgullapalli@salud.unm.edu  Q: A recent New York Times… Read more »